Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Conditions
PainProstate Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

PROCEDURE

pain therapy

Trial Locations (6)

10595

New York Medical College, Valhalla

11021

Arena Oncology Associates, Great Neck

19013

Associates of Hematology/Oncology, Upland

28603

N.W. Carolina Oncology & Hematology, P.A., Hickory

90057

Wilshire Oncology Medical Group, Inc., Los Angeles

32960-6541

Geffen Cancer Center and Research Institute, Vero Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY